Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Cody P Coyne & Lakshmi Narayanan. (2016) Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549). Drug Design, Development and Therapy 10, pages 2575-2597.
Read now
Read now
Articles from other publishers (15)
Victoria O. Shipunova, Elena N. Komedchikova, Polina A. Kotelnikova, Ivan V. Zelepukin, Alexey A. Schulga, Galina M. Proshkina, Elena I. Shramova, Hilliard L. Kutscher, Georgij B. Telegin, Andrei V. Kabashin, Paras N. Prasad & Sergey M. Deyev. (2020) Dual Regioselective Targeting the Same Receptor in Nanoparticle-Mediated Combination Immuno/Chemotherapy for Enhanced Image-Guided Cancer Treatment. ACS Nano 14:10, pages 12781-12795.
Crossref
Crossref
Cody P. Coyne & Lakshmi Narayanan. (2019) Carnosic Acid, Tangeretin, and Ginkgolide-B Anti-neoplastic Cytotoxicity in Dual Combination with Dexamethasone-[anti-EGFR] in Pulmonary Adenocarcinoma (A549). Anti-Cancer Agents in Medicinal Chemistry 19:6, pages 802-819.
Crossref
Crossref
Cody P. Coyne & Lakshmi Narayanan. (2018) Anti-neoplastic cytotoxicity by complementary simultaneous selective “targeted” delivery for pulmonary adenocarcinoma: fludarabine-(5′-phosphoramidate)-[anti-IGF-1R] in dual-combination with dexamethasone-(C21-phosphoramidate)-[anti-EGFR]. Journal of Pharmaceutical Investigation 49:1, pages 173-193.
Crossref
Crossref
Cody P. Coyne & Lakshmi Narayanan. (2017)
Gemcitabine-(
5′-phosphoramidate
)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)
. Chemical Biology & Drug Design 89:3, pages 379-399.
Crossref
Crossref
Seth H. Pincus, Kejing Song, Grace A. Maresh, Anderson Frank, David Worthylake, Hye-Kyung Chung, Patricia Polacino, Dean H. Hamer, Cody P. Coyne, Michael G. Rosenblum, John W. Marks, Gang Chen, Deborah Weiss, Victor Ghetie, Ellen S. Vitetta, James E. Robinson & Shiu-Lok Hu. (2017)
Design and
In Vivo
Characterization of Immunoconjugates Targeting HIV gp160
. Journal of Virology 91:3.
Crossref
Crossref
C. P. Coyne, Toni Jones & Ryan Bear. (2015) Simultaneous Dual Selective Targeted Delivery of Two Covalent Gemcitabine Immunochemotherapeutics and Complementary Anti-Neoplastic Potency of [Se]-Methylselenocysteine. Journal of Cancer Therapy 06:01, pages 62-89.
Crossref
Crossref
J.M. Nabholtz, C. Abrial, M.A. Mouret-Reynier, M.M. Dauplat, B. Weber, J. Gligorov, A.M. Forest, O. Tredan, L. Vanlemmens, T. Petit, S. Guiu, I. Van Praagh, C. Jouannaud, P. Dubray-Longeras, N. Tubiana-Mathieu, K.E. Benmammar, S. Kullab, M.R.K. Bahadoor, N. Radosevic-Robin, F. Kwiatkowski, A. Desrichard, A. Cayre, N. Uhrhammer, N. Chalabi, P. Chollet & F. Penault-Llorca. (2014) Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact. Annals of Oncology 25:8, pages 1570-1577.
Crossref
Crossref
Yijie Lu, Ghislaine Ngo Ndjock Mbong, Peng Liu, Conrad Chan, Zhongli Cai, Dirk Weinrich, Amanda J. Boyle, Raymond M. Reilly & Mitchell A. Winnik. (2014) Synthesis of Polyglutamide-Based Metal-Chelating Polymers and Their Site-Specific Conjugation to Trastuzumab for Auger Electron Radioimmunotherapy. Biomacromolecules 15:6, pages 2027-2037.
Crossref
Crossref
Peng Liu, Zhongli Cai, Jae W. Kang, Amanda J. Boyle, Jarret Adams, Yijie Lu, Ghislaine Ngo Ndjock Mbong, Sachdev Sidhu, Raymond M. Reilly & Mitchell A. Winnik. (2014) Intracellular Routing in Breast Cancer Cells of Streptavidin-Conjugated Trastuzumab Fab Fragments Linked to Biotinylated Doxorubicin-Functionalized Metal Chelating Polymers. Biomacromolecules 15:3, pages 715-725.
Crossref
Crossref
Chetan Yewale, Dipesh Baradia, Imran Vhora, Sushilkumar Patil & Ambikanandan Misra. (2013) Epidermal growth factor receptor targeting in cancer: A review of trends and strategies. Biomaterials 34:34, pages 8690-8707.
Crossref
Crossref
Wenqing Tang, Shuqiang Weng, Si Zhang, Weibing Wu, Ling Dong, Xizhong Shen, Songwen Zhang, Jianxin Gu & Ruyi Xue. (2013) Direct interaction between surface β1,4-galactosyltransferase 1 and epidermal growth factor receptor (EGFR) inhibits EGFR activation in hepatocellular carcinoma. Biochemical and Biophysical Research Communications 434:3, pages 449-454.
Crossref
Crossref
Cody P. CoyneToni JonesRyan Bear. (2012)
Synthesis of a Covalent Epirubicin-(C
3
-
amide
)-Anti-HER2/
neu
Immunochemotherapeutic Utilizing a UV-Photoactivated Anthracycline Intermediate
. Cancer Biotherapy and Radiopharmaceuticals 27:1, pages 41-55.
Crossref
Crossref
Cody P. Coyne, Toni Jones & Ryan Bear. (2012) Synthesis of Gemcitabine-(C<sub>4</sub>-<i>amide</i>)-[anti-HER2/<i>neu</i>] Utilizing a UV-Photoactivated Gemcitabine Intermediate: Cytotoxic Anti-Neoplastic Activity against Chemotherapeutic-Resistant Mammary Adenocarcinoma SKBr-3. Journal of Cancer Therapy 03:05, pages 689-711.
Crossref
Crossref
Cody P. Coyne, Toni Jones, Andrzej Sygula, John Bailey & Lesya Pinchuk. (2011) Epirubicin-[Anti-HER2/neu] Synthesized with an Epirubicin-(C13-imino)-EMCS Analog: Anti-Neoplastic Activity against Chemotherapeutic-Resistant SKBr-3 Mammary Carcinoma in Combination with Organic Selenium. Journal of Cancer Therapy 02:01, pages 22-39.
Crossref
Crossref
C.P. Coyne, Toni Jones & Todd Pharr. (2011) Synthesis of a covalent gemcitabine-(carbamate)-[anti-HER2/neu] immunochemotherapeutic and its cytotoxic anti-neoplastic activity against chemotherapeutic-resistant SKBr-3 mammary carcinoma. Bioorganic & Medicinal Chemistry 19:1, pages 67-76.
Crossref
Crossref